UPC_OUT_1 [2025-04-28 14:05:15 -0400] 6593 Bytes | 1665 tokens | Cum: 1665 tkns (20.81% of 8k)
==========================================================================

Listen up, partner—it's 2:05 PM on Mon Apr 28, 2025, and I’m revved up about Universe Pharmaceuticals (UPC), climbing from $4.20 to $4.85. This stock is buzzing big-time—do we have a hidden gem, or a flash in the pan? Help me sift through the data!

--- COMPANY PROFILE ---
Company: Universe Pharmaceuticals (UPC)
IPO: 2021-03-23 (4 Years Ago)
Market Cap: $1,088,599
Shares Outstanding: 180,000
Exchange: XNAS
Description: Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.

Here’s a list of headlines for Universe Pharmaceuticals:

Mar-20-25 08:42AM - Universe Pharmaceuticals to conduct share consolidation
Mar-20-25 08:42AM 08:30AM - Universe Pharmaceuticals INC Announces Share Consolidation
Feb-25-25 04:10PM - Universe Pharmaceuticals INC Receives Staff Determination Notice from Nasdaq Related to Delayed Annual Report
Feb-03-25 04:10PM - Universe Pharmaceuticals INC Receives Nasdaq Delisting Notice Subject to Hearing Request
Dec-10-24 05:00PM - Univest Securities, LLC Announces Closing of $15 Million Registered Direct Offering for its Client Universe Pharmaceuticals INC (NASDAQ: UPC)
Dec-09-24 07:00AM - Universe Pharmaceuticals INC Announces $15 Million Registered Direct Offering
Nov-13-24 08:00AM - Universe Pharmaceuticals INC Announces Share Consolidation
Nov-01-24 04:00PM - Universe Pharmaceuticals INC Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
Sep-20-24 04:15PM - Universe Pharmaceuticals INC Reports Financial Results for The First Six Months of Fiscal Year 2024
Sep-19-24 12:39PM - Fall Trends in Shareholder Activism: Vinson & Elkins Partner Patrick Gadson, Live from NYSE
Jul-15-24 07:35AM - Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Jul-03-24 07:21AM - Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Feb-20-24 08:32AM - Why Is Universe Pharmaceuticals (UPC) Stock Down 29% Today?
Jan-30-24 04:30PM - Universe Pharmaceuticals INC Reports Fiscal Year 2023 Financial Results
Aug-04-23 08:30AM - Universe Pharmaceuticals INC Announces Receipt of Nasdaq Notification Regarding Minimum Market Value of Publicly Held Shares
Jul-27-23 10:15AM - Universe Pharmaceuticals INC Announces Share Consolidation
Mar-07-23 08:00AM - Universe Pharmaceuticals INC Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
Dec-21-22 08:00AM - Universe Pharmaceuticals INC Announces Inclusion of Six Products into the First Edition of Catalogue of Medicine for Patients Infected with COVID-19
Nov-14-22 08:00AM - Universe Pharmaceuticals INC Regains Compliance with Nasdaq Minimum Bid Price Requirement
Aug-16-22 08:00AM - Universe Pharmaceuticals INC Reports Financial Results for The First Six Months of Fiscal Year 2022
Jul-19-22 06:00AM - Universe Pharmaceuticals INC Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
Mar-30-22 08:00AM - Universe Pharmaceuticals INC Announces Strategic Partnership with Lian-Ou Health to Develop its Digital Marketing and Sales on E-Commerce Platforms

Prior AI Reports for UPC:
1. 2025-04-16 – Score: 15 – Target: 3.5000 – Highs: 5.2200 / 3.9371 / 5.47
universe-pharmaceuticals-faces-steep-challenges-amid-declining-sales
2. 2025-04-04 – Score: 15 – Target: 3.5994 – Highs: 3.7341 / 3.3600 / 4.70
plummeting-sales-and-negative-returns-signal-tough-times-ahead
3. 2025-03-25 – Score: 20 – Target: 5.3000 – Highs: 5.6400 / 4.9700 / 5.36
universe-pharmaceuticals-faces-bleak-projections-amidst-steep-sales-decline
4. 2025-03-24 – Score: 15 – Target: 4.3000 – Highs: 4.3900 / 5.6400 / 4.97
universe-pharmaceuticals-declining-sales-performance-concerns-loom

(Note: Highs = Same day / 2nd day / 3rd day)

Here's another list of headlines with menu handles.
I will deliver the full text of the following stories when you say their handle.
Just say, for example, B1, B2, etc.

B1 - 2024-11-01T20:00:00Z - Universe Pharmaceuticals INC Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
B2 - 2024-02-20T18:21:11Z - Why Fluor Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
B3 - 2024-02-20T13:09:16Z - Why Discover Financial Services Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
B4 - 2024-01-08T18:36:30Z - Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
B5 - 2023-08-04T12:30:00Z - Universe Pharmaceuticals INC Announces Receipt of Nasdaq Notification Regarding Minimum Market Value of Publicly Held Shares
B6 - 2023-07-27T14:15:00Z - Universe Pharmaceuticals INC Announces Share Consolidation

==============
-> THE ROLE FOR AI:
==============

1) You are the **AI analyst-investigator**, and this interaction represents a full **due diligence session** for Universe Pharmaceuticals (UPC).
Due diligence includes financial data, insider trading, relevant news, and any SEC filings — and may extend beyond classic fundamentals.
Your task is to identify whether this stock has momentum and potential.

2) I am **ScanScor**, a unified report generator that archives this session as part of our real-time diligence record.

3) You will request information by referencing documents by their code.

4) As the analysis proceeds, your are encouraged to review documents until you feel confident in your judgment.
After seeing 3 sets of news articles, SEC docs, and financials, you'll be prompted to return some data pairs.

5) News articles, SEC filings, and key metrics will be revealed in subsequent prompts.

Stay focused. Gather evidence. Continue until your conclusions are clear.
Restrict all your responses to just 3 tokens until the summary and data pairs at the end.

NEXT: Request a document with its reference code(s), such as:
- `B1`, `B2`, `B3`, etc.
- To load a new set of information and menu options, reply with: `NEX`

UPC_OUT_3 [2025-04-28 14:05:17 -0400] 987 Bytes | 307 tokens | Cum: 1974 tkns (24.68% of 8k)
==========================================================================

We present this news so you can catch the big movers from recently breaking news.
Here's a list of news articles you can literally read just by asking.
Usually the first item is the most important.

A1 - 2025-04-22T12:06:53Z - 12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Gelteq (NASDAQ:GELS), iBio (NASDAQ:IB...
A2 - 2025-04-22T11:54:00Z - Pre-market Movers: GELS, HOLO, SHFS, OBIO, FULC....
A3 - 2025-04-21T21:05:49Z - 12 Health Care Stocks Moving In Monday's After-Market Session - Annovis Bio (NYSE:ANVS), Adial Pharm...
A4 - 2025-04-16T17:06:28Z - 12 Health Care Stocks Moving In Wednesday's Intraday Session - Biomerica (NASDAQ:BMRA), Acrivon Ther...
A5 - 2025-04-16T12:07:22Z - 12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Adaptive Biotechnologies (NASDAQ:AD...

Request an article by its reference number. (Ex., "A1" gets the first item)
You may also say NEX to go to the next listing.
Response to this prompt limited to 3 chars.

UPC_OUT_5 [2025-04-28 14:05:17 -0400] 1181 Bytes | 364 tokens | Cum: 2340 tkns (29.25% of 8k)
==========================================================================

Showing A1 (chunk 1 of 3): A1:
**12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Gelteq (NASDAQ:GELS), iBio (NASDAQ:IBIO)**Date: 2025-04-22Source: {'uri': 'benzinga.com', 'dataType': 'news', 'title': 'Benzinga'}URL: https://www.benzinga.com/insights/movers/25/04/44919729/12-health-care-stocks-moving-in-tuesdays-pre-market-sessionGainers Gelteq GELS shares increased by 371.1% to $4.24 during Tuesday's pre-market session. The market value of their outstanding shares is at $40.0 million. Ocean Biomedical OCEA stock increased by 59.0% to $0.06. The company's market cap stands at $10.5 million. Orchestra BioMed Hldgs OBIO shares rose 28.52% to $3.65. The company's market cap stands at $138.0 million. Palatin Techs PTN stock rose 20.99% to $0.28. The market value of their outstanding shares is at $7.2 million. iBio IBIO stock rose 20.31% to $1.02. The market value of their outstanding shares is at $10.0 m

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

UPC_OUT_7 [2025-04-28 14:05:18 -0400] 1181 Bytes | 343 tokens | Cum: 2685 tkns (33.56% of 8k)
==========================================================================

Showing A1 (chunk 2 of 3): illion. China SXT Pharmaceuticals SXTC shares increased by 16.66% to $1.19. The company's market cap stands at $16.3 million. Losers Vincerx Pharma VINC stock declined by 22.9% to $0.1 during Tuesday's pre-market session. Sionna Therapeutics SION stock fell 17.53% to $9.32. The company's market cap stands at $409.9 million. Outset Medical OM shares fell 16.74% to $8.31. The market value of their outstanding shares is at $147.2 million. Tyra Biosciences TYRA stock decreased by 16.01% to $7.61. The market value of their outstanding shares is at $404.0 million. Klotho Neurosciences KLTO stock fell 13.96% to $0.14. The market value of their outstanding shares is at $3.8 million. Universe Pharmaceuticals UPC stock declined by 12.08% to $3.64. The company's market cap stands at $55.4 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's aut

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

UPC_OUT_9 [2025-04-28 14:05:19 -0400] 991 Bytes | 331 tokens | Cum: 3018 tkns (37.72% of 8k)
==========================================================================

Showing A1 (chunk 3 of 3): omated content engine and reviewed by an editor.

GELSGelteq Ltd$4.46395.6%Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock - anytime.

Reveal Full ScoreEdge RankingsMomentum-Price TrendShortMediumLongOverviewIBIOiBio Inc$0.966714.0%KLTOKlotho Neurosciences Inc$0.1359-13.4%OBIOOrchestra BioMed Holdings Inc$3.6327.8%OCEAOcean Biomedical Inc$0.0400-%OMOutset Medical Inc$8.30-16.8%PTNPalatin Technologies Inc$0.2087-9.65%SIONSionna Therapeutics Inc$9.32-17.5%SXTCChina SXT Pharmaceuticals Inc$1.3027.4%TYRATyra Biosciences Inc$7.60-16.1%UPCUniverse Pharmaceuticals Inc$3.63-12.3%VINCVincerx Pharma Inc$0.0960-28.0%Market News and Data brought to you by Benzinga APIs

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

UPC_OUT_11 [2025-04-28 14:05:20 -0400] 238 Bytes | 59 tokens | Cum: 3079 tkns (38.49% of 8k)
==========================================================================

This is our list of SEC filings.
If empty, the search returned no recent filings.

Request filing by its reference number. (Ex., "S1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

UPC_OUT_13 [2025-04-28 14:05:24 -0400] 251 Bytes | 78 tokens | Cum: 3160 tkns (39.50% of 8k)
==========================================================================

You just read a chunk of S1.
You may now:
- Say "MOR" to continue this article
- Say "S2", "S3", etc. to request another
- Or say "NEX" to move to the next source

You are allowed up to 6 articles from this list. If you’re ready to move on, say NEX.

UPC_OUT_15 [2025-04-28 14:05:29 -0400] 5028 Bytes | 1171 tokens | Cum: 4334 tkns (54.17% of 8k)
==========================================================================

This is our set of metrics for Universe Pharmaceuticals.
Please analyze the numbers.

+---------------------+-----------------------+------------------------+------------------------+
| Volume: 142,451 | Perf Month: -12.31% | Option/Short: No / Yes | Sales Y/Y TTM: -22.33% |
+---------------------+-----------------------+------------------------+------------------------+
| Avg Volume: 420.78K | Perf Quarter: -76.56% | Short Float: 3.51% | ROE: -50.22% |
+---------------------+-----------------------+------------------------+------------------------+
| Rel Volume: 0.50 | Index: - | Short Ratio: 0.02 | ROI: -64.36% |
+---------------------+-----------------------+------------------------+------------------------+
| RSI (14): 54.06 | Market Cap: 1.02M | Short Interest: 0.01M | Sales Surprise: - |
+---------------------+-----------------------+------------------------+------------------------+
| ATR (14): 0.92 | Shs Outstand: 3.65M | Beta: 1.54 | EPS Surprise: - |
+---------------------+-----------------------+------------------------+------------------------+
| SMA20: 31.19% | Shs Float: 0.21M | Sales Q/Q: -30.23% | P/E: - |
+---------------------+-----------------------+------------------------+------------------------+
| SMA50: 4.16% | Inst Own: 6.51% | Sales past 5Y: - | Earnings: - |
+---------------------+-----------------------+------------------------+------------------------+
| SMA200: -99.09% | Insider Own: 1.91% | Employees: - | |
+---------------------+-----------------------+------------------------+------------------------+
| Perf Week: 13.53% | Insider Trans: 0.00% | Debt/Eq: 0.24 | |
+---------------------+-----------------------+------------------------+------------------------+

The next section covers any insider trading by Universe Pharmaceuticals officers or majority shareholders (if available).

[Company Financial Summary]
[Company Details]
Name: N/A
Market Cap: N/A
Shares Outstanding: N/A
Sector: N/A

[Financial Statements - Latest Quarter]
Total Assets: N/A
Total Liabilities: N/A
Total Equity: N/A
Revenue (Quarter): N/A
Net Income: N/A
Earnings Per Share (EPS): N/A

[Price Metrics - Last 30 Days]
Latest Close: 4.8499
Average Volume: 405679.75
30-Day High: 4.8499
30-Day Low: 2.85
No detailed financial data available.
==== END OF FINANCIAL REPORT ====

You are now requested to write a summary analysis of Universe Pharmaceuticals (UPC).

Please complete the report using the exact format:
FIELD[value]

1) BRIEF_SUMMARY[]
One well-worded paragraph summarizing your findings about Universe Pharmaceuticals.

2) MARKET_SCORE[]
This conversation was initiated because UPC is currently experiencing upward price and volume movement.
Estimate a number between 1–100 based on the likelihood of a continued upward price move for UPC.
Weigh relevant data — news, filings, fundamentals, and metrics — and assign appropriate weight.

3) PRICE_TARGET[]
Suggest a price, based on all prior evidence and past price behavior, UPC could reach in the current or upcoming trading sessions (1–5 days).
For example, if you expect UPC to increase 50% from its current price of $0.00, say: PRICE_TARGET[0.0]

4) AI_RPT_HEADLINE[]
Write a thought-provoking 8–12 word headline summarizing this report.

5) SQUEEZE_POTENTIAL[]
Give a score from 1 to 100 representing the potential for this stock to become an active short squeeze play.
Be honest and unbiased. Consider short interest/float, price movement, volume, news strength, and volatility potential.

6) TAGS[]
List 3–6 comma-separated tags (e.g., biotech, earnings beat, squeeze setup)

7) STOCK_TYPE[]
Choose the most accurate classification: growth, value, turnaround, hype, squeeze, dividend, speculative, or other.

8) PRIMARY_CATALYST[]
e.g., earnings report, FDA approval, partnership, etc.

9) SENTIMENT[]
bullish, bearish, neutral, or mixed

10) IMPROVEMENT_SUGGESTION[]
If you believe some key info was missing, state what would have significantly improved your analysis of Universe Pharmaceuticals.

11) ETHICAL_RATING[]
Rate Universe Pharmaceuticals’s alignment with long-term shareholder interests, using a letter grade from A (high alignment) to F (low alignment).
Base this on actions such as insider buying/selling, share dilution, follow-through on public statements, and compensation practices.

12) UPCOMING_CATALYST[]
Specify any upcoming events you expect would be a catalyst affecting the share-price of Universe Pharmaceuticals.
Provide any reasons you can use to support it.

Return only: FIELD[value] for each of the above 12 questions.
Respond with all data pairs. Take your best guess if you have to, but don't leave blank items.
Do not explain your answers. Return only the required fields in the exact format shown.

Finally, thank you for participating!

UPC_IN_17 [2025-04-28 14:05:29 -0400] 126 Bytes | 29 tokens | Cum: 4547 tkns (56.84% of 8k)
==========================================================================

====================================
[2025-04-28 14:05:29] # Analysis Completed
Elapsed Time: 14.94 seconds